BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 13091943)

  • 1. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
    KOELZER PP; WEHR KH; GIESEN J
    Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
    [No Abstract]   [Full Text] [Related]  

  • 2. [On PAS calcium salts].
    SMOLAREK W
    Tuberkulosearzt; 1953 May; 7(5):303-5. PubMed ID: 13090340
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic evaluation of para-aminosalicylic acid granules.
    Peloquin CA; Henshaw TL; Huitt GA; Berning SE; Nitta AT; James GT
    Pharmacotherapy; 1994; 14(1):40-6. PubMed ID: 8159600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PAS concentration in blood in therapeutic use of PAS and its salts].
    NILSSON H
    Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
    BANG HO; STRANDGAARD E
    Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
    [No Abstract]   [Full Text] [Related]  

  • 6. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 7. [Para-aminosalicylic acid and streptomycin blood level in renal tuberculosis].
    HOESS H; LAUENER H; SCHONHOLZER G
    Urol Int; 1956; 3(2-3):114-21. PubMed ID: 13401594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of PAS on blood picture in tuberculosis].
    PARAF J; DESBORDES J; ZIVY P
    Sang; 1952; 23(7):616-8. PubMed ID: 13004917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of blood and cerebrospinal fluid levels of para-aminosalicylic acid in children affected with meningeal tuberculosis, with special reference to the blood-spinal fluid quotient].
    VIGNOLO-LUTATI U; GAMALERO PC
    Minerva Pediatr; 1953 Apr; 5(7):241-5. PubMed ID: 13072133
    [No Abstract]   [Full Text] [Related]  

  • 10. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
    CITRON KM; KUPER SW
    Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
    Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H
    J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
    NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
    Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
    RIEBER CW; SALINE M; FRIEDMAN MM
    Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
    [No Abstract]   [Full Text] [Related]  

  • 14. The concentration of PAS in the blood during medication with PAS or PAS-salts.
    NILSSON H
    Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum isoniazid concentrations in Japanese tuberculosis patients and the effect of the simultaneous administration of PAS.
    REI TS
    Jpn J Microbiol; 1960 Jan; 4():1-6. PubMed ID: 13740408
    [No Abstract]   [Full Text] [Related]  

  • 16. 4-Aminosalicylic acid blood levels following oral administration of sodium 4-aminosalicylate and calcium 4-benzamidosalicylate.
    DRAIN DJ; LAZARE R; TATTERSALL K
    Tubercle; 1959 Jun; 40():201-4. PubMed ID: 13817982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral administration of PAS].
    RENARD J; COULET M; RIMBAULT Y
    Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
    [No Abstract]   [Full Text] [Related]  

  • 18. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PAS blood content after peroral intake of different calcium-PAS-granulates].
    SANZ MC; MULLER A
    Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
    Miroshnichenko II; Sokolova GB; Mokhireva LV
    Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.